COMPANY OVERVIEW

Axial Biotherapeutics is a biopharmaceutical company harnessing the link between the human gut microbiome and Central Nervous System to develop a new class of therapeutics to improve the quality of life for people with CNS diseases and disorders

---

LOCATION

Waltham, MA, USA

---

THERAPEUTIC AREAS

Neurological Disorders

---

WEBSITE

https://www.axialbiotherapeutics.com/

---

CAREER WEBSITE

https://www.axialbiotherapeutics.com/careers/

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

Dec 8, 2020

Axial Biotherapeutics to Present at the 2020 RBC Capital Markets Healthcare Private Company Conference

Sep 22, 2020

Axial Biotherapeutics Appoints Federico Bolognani, M.D., Ph.D., Vice President and Head of Clinical Science

Aug 17, 2020

Axial Biotherapeutics to Present at The JMP Securities CNS Forum

Jul 28, 2020

Axial Biotherapeutics Announces a Research Grant Award from The Michael J. Fox Foundation for the Development of an Enteric Nervous System Model to Assess Novel Parkinson’s Disease Therapeutics

May 27, 2020

Axial Biotherapeutics to Present at the Jefferies Virtual Global Healthcare Conference

For More Press Releases

---